Drugs / Peru-15 pCTB
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00654108 | Jun 2008 → May 2010 | gastroenteritis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peru-15 pCTB | “Live attenuated oral combined ETEC-cholera (Peru-15 pCTB) vaccine co-administered with bicarbonate buffer solution” NCT00654108 ↗ |
| Modality | Vaccine | “a combined live, attenuated, enterotoxigenic Escherichia coli (ETEC)-cholera vaccine” NCT00654108 ↗ |
| Route | Oral | “single oral dose of a combined live, attenuated, enterotoxigenic Escherichia coli (ETEC)-cholera vaccine” NCT00654108 ↗ |